Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Novel panaxatriol derivative shows efficacy in rat model of MI/R injury

Jan. 27, 2020

Fat or fiber, cFAP activation is problematic for heart

Jan. 27, 2020

FDA approves Ozempic to reduce MACE in adults with type 2 diabetes and heart disease

Jan. 17, 2020

HDAC blockade seen to restore cardiopulmonary function in felines

Jan. 16, 2020

Cynata receives approval for its U.K. phase II study in critical limb ischemia

Jan. 15, 2020

Targeting SMPD1 ameliorates leptin resistance-derived endothelial dysfunction in rats

Jan. 15, 2020

New cardiac sarcomere inhibitors discovered at Cytokinetics

Jan. 14, 2020

Novartis opens phase III study of TQJ-230 in patients with cardiovascular disease

Jan. 14, 2020

AKCEA-TTR-LRx begins phase III cardiovascular outcomes study

Jan. 13, 2020

Merck & Co. discovers PCSK9 inhibitors

Jan. 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...